Completed PHASE2 INTERVENTIONAL 2-arm NCT00764231

A Study of a Home-based Exercise Intervention for Patients With Acute Myeloid Leukaemia (AML)

A Pilot Study of a Home-based Exercise Intervention for Patients With AML

Sponsor: The Leukemia and Lymphoma Society

Conditions Acute Myeloid Leukemia Exercise Fatigue Quality of Life

Interventions Home-based exercise program Wait list

Updated 5 times since 2017 Last updated: Feb 7, 2012 Started: Oct 31, 2008 Primary completion: Feb 28, 2011 Completion: Apr 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00764231, this PHASE2 trial focuses on Acute Myeloid Leukemia and Exercise and remains completed. Sponsored by The Leukemia and Lymphoma Society, it has been updated 5 times since 2008, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Oct 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The Leukemia and Lymphoma Society
Toronto Rehabilitation Institute
University Health Network, Toronto

Data source: Toronto Rehabilitation Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Toronto, Canada